Skip to main content

CTOS 2023 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Katherine A. Janeway, MD

Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

Paper 08 - NETWORK-BASED INFERENCE IDENTIFIES PROGNOSTIC SIGNATURES AND DRUGS TARGETING MASTER REGULATORS OF DISTINCT CELL STATES IN OSTEOSARCOMA

Thursday, November 2, 2023
11:00 AM – 12:30 PM
Paper 18 - PREOPERATIVE RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA TREATED ON AEWS1031: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

Thursday, November 2, 2023
2:00 PM – 3:30 PM
Paper 45 - ANALYSIS OF A LARGE OSTEOSARCOMA SEQUENCING DATASET IDENTIFIES DIFFERENCES IN GENOMICS ACROSS THE AGE SPECTRUM

Friday, November 3, 2023
2:30 PM – 4:00 PM
Paper 65 - PRE-TREATMENT CTDNA BURDEN AND GENOMIC FEATURES ARE PROGNOSTIC AMONG PATIENTS WITH METASTATIC EWING SARCOMA TREATED ON AEWS1221: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)

Saturday, November 4, 2023
10:00 AM – 11:00 AM
Paper 66 - ARE TREATMENT DELAYS ASSOCIATED WITH A WORSE OUTCOME IN PATIENTS WITH HIGH-GRADE OSTEOSARCOMA? A RETROSPECTIVE ANALYSIS OF DATA FROM THE EURAMOS-1 TRIAL

Saturday, November 4, 2023
10:00 AM – 11:00 AM
Paper 67 - SIGNIFICANCE OF EARLY LOCAL PROGRESSION IN NEWLY DIAGNOSED HIGH-GRADE OSTEOSARCOMA- A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

Saturday, November 4, 2023
10:00 AM – 11:00 AM